Gyrase and Topoisomerase IV as Antibacterial Targets for Gepotidacin and Zoliflodacin: Teaching Old Enzymes New Tricks. [PDF]
Osheroff N.
europepmc +1 more source
Safety of Fluoroquinolones and Cotrimoxazole in Urinary Tract Infections in Older Males. [PDF]
Gouraud C +8 more
europepmc +1 more source
Antibiotic therapy as a risk factor for chronic residual and phantom limb pain after combat-related amputation: a 212-patient cohort study. [PDF]
Ksenchyna K +3 more
europepmc +1 more source
A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones. [PDF]
Itoh K +4 more
europepmc +1 more source
Epidemiological burden of multidrug-resistant bacteria and carbapenemases in Northern Morocco: a one-year observational study. [PDF]
El Harrak K +9 more
europepmc +1 more source
The Role of the SOS Response in the Adaptation of <i>Pseudomonas aeruginosa</i>. [PDF]
Zarembska E +2 more
europepmc +1 more source
Antimicrobial susceptibility and adaptative changes in MRSA lineages exposed to increasing concentrations of fluoroquinolones and chlorhexidine. [PDF]
de Oliveira TLR +6 more
europepmc +1 more source
Risk of drug eruption associated with the use of tetracyclines, macrolides, and fluoroquinolones: real-world evidence from a pharmacovigilance study utilizing the FDA adverse event reporting system. [PDF]
Alshammari TM.
europepmc +1 more source
Empiric outpatient antibiotic prescribing patterns in the emergency department. [PDF]
Badwal A +4 more
europepmc +1 more source
HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to Fluoroquinolones. [PDF]
Nicoletti P +10 more
europepmc +1 more source

